APO Research
Talk to an analyst

APO RESEARCH · REPORT

Polymers Drug Delivery

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Polymers Drug Delivery Market Outlook and Growth Opportunities 2026

20 December 2025203 pages

Choose your research edition.

Industry ResearchPolymers Drug Delivery Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Polymers Drug Delivery Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Polymers Drug Delivery Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Polymers Drug Delivery Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Polymers Drug Delivery Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Polymers Drug Delivery market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Polymers Drug Delivery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Polymers Drug Delivery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Polymers Drug Delivery is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Polymers Drug Delivery market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Polymers Drug Delivery market include Eisai, Sanofi, Johnson & Johnson, Vectura Group Plc, Tolmar, SurModics, Quark Pharmaceuticals Inc, Perrigo and Nektar Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Polymers Drug Delivery market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Polymers Drug Delivery and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Polymers Drug Delivery revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Polymers Drug Delivery market.

Polymers Drug Delivery Segment by Company

Eisai

Sanofi

Johnson & Johnson

Vectura Group Plc

Tolmar

SurModics

Quark Pharmaceuticals Inc

Perrigo

Nektar Therapeutics

Janssen Biotech

Inovio Pharmaceuticals

Heron

Gilead Sciences

Enzon Pharmaceuticals

EnColl Corporation

Allergan

Alkermes

Polymers Drug Delivery Segment by Type

Micelles

Dendrimer

Hydrogels

Microgels

Other

Polymers Drug Delivery Segment by Application

Medical Research Center

Pharmaceutical Factory

Other

Polymers Drug Delivery Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Polymers Drug Delivery status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Polymers Drug Delivery key companies, revenue, market share, and recent developments.

3. To split the Polymers Drug Delivery breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Polymers Drug Delivery market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Polymers Drug Delivery significant trends, drivers, influence factors in global and regions.

6. To analyze Polymers Drug Delivery competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polymers Drug Delivery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Polymers Drug Delivery and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polymers Drug Delivery.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Polymers Drug Delivery industry.

Chapter 3: Detailed analysis of Polymers Drug Delivery company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Polymers Drug Delivery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Polymers Drug Delivery in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Polymers Drug Delivery Industry Trends Table 2. Polymers Drug Delivery Industry Drivers Table 3. Polymers Drug Delivery Industry Opportunities and Challenges Table 4. Polymers Drug Delivery Industry Restraints Table 5. Global Polymers Drug Delivery Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Polymers Drug Delivery Revenue Share by Company (2021-2026) Table 7. Global Polymers Drug Delivery Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Polymers Drug Delivery Key Company Manufacturing Base & Headquarters Table 9. Global Polymers Drug Delivery Company, Product Type & Application Table 10. Global Polymers Drug Delivery Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Polymers Drug Delivery by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Micelles Table 15. Significant Companies of Dendrimer Table 16. Significant Companies of Hydrogels Table 17. Significant Companies of Microgels Table 18. Significant Companies of Other Table 19. Global Polymers Drug Delivery Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Polymers Drug Delivery Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Polymers Drug Delivery Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Polymers Drug Delivery Sales Value Share by Type (2021-2026) Table 23. Global Polymers Drug Delivery Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Medical Research Center Table 25. Significant Companies of Pharmaceutical Factory Table 26. Significant Companies of Other Table 27. Global Polymers Drug Delivery Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Polymers Drug Delivery Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Polymers Drug Delivery Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Polymers Drug Delivery Sales Value Share by Application (2021-2026) Table 31. Global Polymers Drug Delivery Sales Value Share by Application (2027-2032) Table 32. Global Polymers Drug Delivery Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Polymers Drug Delivery Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Polymers Drug Delivery Sales Value Share by Region (2021-2026) Table 35. Global Polymers Drug Delivery Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Polymers Drug Delivery Sales Value Share by Region (2027-2032) Table 37. Global Polymers Drug Delivery Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Polymers Drug Delivery Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Polymers Drug Delivery Sales Value Market Share by Country (2021-2026) Table 40. Global Polymers Drug Delivery Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Polymers Drug Delivery Sales Value Market Share by Country (2027-2032) Table 42. Eisai Company Information Table 43. Eisai Business Overview Table 44. Eisai Polymers Drug Delivery Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Eisai Polymers Drug Delivery Product Portfolio Table 46. Eisai Recent Development Table 47. Sanofi Company Information Table 48. Sanofi Business Overview Table 49. Sanofi Polymers Drug Delivery Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Sanofi Polymers Drug Delivery Product Portfolio Table 51. Sanofi Recent Development Table 52. Johnson & Johnson Company Information Table 53. Johnson & Johnson Business Overview Table 54. Johnson & Johnson Polymers Drug Delivery Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Johnson & Johnson Polymers Drug Delivery Product Portfolio Table 56. Johnson & Johnson Recent Development Table 57. Vectura Group Plc Company Information Table 58. Vectura Group Plc Business Overview Table 59. Vectura Group Plc Polymers Drug Delivery Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Vectura Group Plc Polymers Drug Delivery Product Portfolio Table 61. Vectura Group Plc Recent Development Table 62. Tolmar Company Information Table 63. Tolmar Business Overview Table 64. Tolmar Polymers Drug Delivery Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Tolmar Polymers Drug Delivery Product Portfolio Table 66. Tolmar Recent Development Table 67. SurModics Company Information Table 68. SurModics Business Overview Table 69. SurModics Polymers Drug Delivery Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. SurModics Polymers Drug Delivery Product Portfolio Table 71. SurModics Recent Development Table 72. Quark Pharmaceuticals Inc Company Information Table 73. Quark Pharmaceuticals Inc Business Overview Table 74. Quark Pharmaceuticals Inc Polymers Drug Delivery Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Quark Pharmaceuticals Inc Polymers Drug Delivery Product Portfolio Table 76. Quark Pharmaceuticals Inc Recent Development Table 77. Perrigo Company Information Table 78. Perrigo Business Overview Table 79. Perrigo Polymers Drug Delivery Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Perrigo Polymers Drug Delivery Product Portfolio Table 81. Perrigo Recent Development Table 82. Nektar Therapeutics Company Information Table 83. Nektar Therapeutics Business Overview Table 84. Nektar Therapeutics Polymers Drug Delivery Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Nektar Therapeutics Polymers Drug Delivery Product Portfolio Table 86. Nektar Therapeutics Recent Development Table 87. Janssen Biotech Company Information Table 88. Janssen Biotech Business Overview Table 89. Janssen Biotech Polymers Drug Delivery Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Janssen Biotech Polymers Drug Delivery Product Portfolio Table 91. Janssen Biotech Recent Development Table 92. Inovio Pharmaceuticals Company Information Table 93. Inovio Pharmaceuticals Business Overview Table 94. Inovio Pharmaceuticals Polymers Drug Delivery Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Inovio Pharmaceuticals Polymers Drug Delivery Product Portfolio Table 96. Inovio Pharmaceuticals Recent Development Table 97. Heron Company Information Table 98. Heron Business Overview Table 99. Heron Polymers Drug Delivery Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Heron Polymers Drug Delivery Product Portfolio Table 101. Heron Recent Development Table 102. Gilead Sciences Company Information Table 103. Gilead Sciences Business Overview Table 104. Gilead Sciences Polymers Drug Delivery Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Gilead Sciences Polymers Drug Delivery Product Portfolio Table 106. Gilead Sciences Recent Development Table 107. Enzon Pharmaceuticals Company Information Table 108. Enzon Pharmaceuticals Business Overview Table 109. Enzon Pharmaceuticals Polymers Drug Delivery Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Enzon Pharmaceuticals Polymers Drug Delivery Product Portfolio Table 111. Enzon Pharmaceuticals Recent Development Table 112. EnColl Corporation Company Information Table 113. EnColl Corporation Business Overview Table 114. EnColl Corporation Polymers Drug Delivery Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. EnColl Corporation Polymers Drug Delivery Product Portfolio Table 116. EnColl Corporation Recent Development Table 117. Allergan Company Information Table 118. Allergan Business Overview Table 119. Allergan Polymers Drug Delivery Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Allergan Polymers Drug Delivery Product Portfolio Table 121. Allergan Recent Development Table 122. Alkermes Company Information Table 123. Alkermes Business Overview Table 124. Alkermes Polymers Drug Delivery Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Alkermes Polymers Drug Delivery Product Portfolio Table 126. Alkermes Recent Development Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Polymers Drug Delivery Product Image Figure 2. Global Polymers Drug Delivery Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Polymers Drug Delivery Market Size (2021-2032) & (US$ Million) Figure 4. Global Polymers Drug Delivery Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Micelles Image Figure 8. Dendrimer Image Figure 9. Hydrogels Image Figure 10. Microgels Image Figure 11. Other Image Figure 12. Global Polymers Drug Delivery Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Polymers Drug Delivery Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Polymers Drug Delivery Sales Value Share by Type (2021-2032) Figure 15. Medical Research Center Image Figure 16. Pharmaceutical Factory Image Figure 17. Other Image Figure 18. Global Polymers Drug Delivery Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Polymers Drug Delivery Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Polymers Drug Delivery Sales Value Share by Application (2021-2032) Figure 21. Global Polymers Drug Delivery Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Polymers Drug Delivery Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Polymers Drug Delivery Sales Value (2021-2032) & (US$ Million) Figure 24. North America Polymers Drug Delivery Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Polymers Drug Delivery Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Polymers Drug Delivery Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Polymers Drug Delivery Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Polymers Drug Delivery Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Polymers Drug Delivery Sales Value (2021-2032) & (US$ Million) Figure 30. South America Polymers Drug Delivery Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Polymers Drug Delivery Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Polymers Drug Delivery Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Polymers Drug Delivery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Polymers Drug Delivery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Polymers Drug Delivery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Polymers Drug Delivery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Polymers Drug Delivery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Polymers Drug Delivery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Polymers Drug Delivery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Polymers Drug Delivery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Polymers Drug Delivery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Polymers Drug Delivery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Polymers Drug Delivery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Polymers Drug Delivery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Polymers Drug Delivery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Polymers Drug Delivery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Polymers Drug Delivery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Polymers Drug Delivery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Polymers Drug Delivery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Polymers Drug Delivery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Polymers Drug Delivery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Polymers Drug Delivery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Polymers Drug Delivery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Polymers Drug Delivery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Polymers Drug Delivery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Polymers Drug Delivery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Polymers Drug Delivery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Polymers Drug Delivery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Polymers Drug Delivery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Polymers Drug Delivery Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Micelles
  • Dendrimer
  • Hydrogels
  • Microgels
  • Other
Applications
  • Medical Research Center
  • Pharmaceutical Factory
  • Other
Companies covered
  • Eisai
  • Sanofi
  • Johnson & Johnson
  • Vectura Group Plc
  • Tolmar
  • SurModics
  • Quark Pharmaceuticals Inc
  • Perrigo
  • Nektar Therapeutics
  • Janssen Biotech
  • Inovio Pharmaceuticals
  • Heron
  • Gilead Sciences
  • Enzon Pharmaceuticals
  • EnColl Corporation
  • Allergan
  • Alkermes

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Polymers Drug Delivery Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Polymers Drug Delivery Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Polymers Drug Delivery Market Dynamics
  1. 2.1 Polymers Drug Delivery Industry Trends
  2. 2.2 Polymers Drug Delivery Industry Drivers
  3. 2.3 Polymers Drug Delivery Industry Opportunities and Challenges
  4. 2.4 Polymers Drug Delivery Industry Restraints
3 Polymers Drug Delivery Market by Company
  1. 3.1 Global Polymers Drug Delivery Company Revenue Ranking in 2025
  2. 3.2 Global Polymers Drug Delivery Revenue by Company (2021-2026)
  3. 3.3 Global Polymers Drug Delivery Company Ranking (2024-2026)
  4. 3.4 Global Polymers Drug Delivery Company Manufacturing Base and Headquarters
  5. 3.5 Global Polymers Drug Delivery Company Product Type and Application
  6. 3.6 Global Polymers Drug Delivery Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Polymers Drug Delivery Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Polymers Drug Delivery Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Polymers Drug Delivery Market by Type
  1. 4.1 Polymers Drug Delivery Type Introduction
  2. 4.1.1 Micelles
  3. 4.1.2 Dendrimer
  4. 4.1.3 Hydrogels
  5. 4.1.4 Microgels
  6. 4.1.5 Other
  7. 4.2 Global Polymers Drug Delivery Sales Value by Type
  8. 4.2.1 Global Polymers Drug Delivery Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Polymers Drug Delivery Sales Value by Type (2021-2032)
  10. 4.2.3 Global Polymers Drug Delivery Sales Value Share by Type (2021-2032)
5 Polymers Drug Delivery Market by Application
  1. 5.1 Polymers Drug Delivery Application Introduction
  2. 5.1.1 Medical Research Center
  3. 5.1.2 Pharmaceutical Factory
  4. 5.1.3 Other
  5. 5.2 Global Polymers Drug Delivery Sales Value by Application
  6. 5.2.1 Global Polymers Drug Delivery Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Polymers Drug Delivery Sales Value by Application (2021-2032)
  8. 5.2.3 Global Polymers Drug Delivery Sales Value Share by Application (2021-2032)
6 Polymers Drug Delivery Regional Value Analysis
  1. 6.1 Global Polymers Drug Delivery Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Polymers Drug Delivery Sales Value by Region (2021-2032)
  3. 6.2.1 Global Polymers Drug Delivery Sales Value by Region: 2021-2026
  4. 6.2.2 Global Polymers Drug Delivery Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Polymers Drug Delivery Sales Value (2021-2032)
  7. 6.3.2 North America Polymers Drug Delivery Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Polymers Drug Delivery Sales Value (2021-2032)
  10. 6.4.2 Europe Polymers Drug Delivery Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Polymers Drug Delivery Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Polymers Drug Delivery Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Polymers Drug Delivery Sales Value (2021-2032)
  16. 6.6.2 South America Polymers Drug Delivery Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Polymers Drug Delivery Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Polymers Drug Delivery Sales Value Share by Country, 2025 VS 2032
7 Polymers Drug Delivery Country-level Value Analysis
  1. 7.1 Global Polymers Drug Delivery Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Polymers Drug Delivery Sales Value by Country (2021-2032)
  3. 7.2.1 Global Polymers Drug Delivery Sales Value by Country (2021-2026)
  4. 7.2.2 Global Polymers Drug Delivery Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Polymers Drug Delivery Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Polymers Drug Delivery Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Polymers Drug Delivery Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Polymers Drug Delivery Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Polymers Drug Delivery Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Polymers Drug Delivery Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Polymers Drug Delivery Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Polymers Drug Delivery Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Polymers Drug Delivery Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Polymers Drug Delivery Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Polymers Drug Delivery Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Polymers Drug Delivery Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Polymers Drug Delivery Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Polymers Drug Delivery Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Polymers Drug Delivery Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Polymers Drug Delivery Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Polymers Drug Delivery Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Polymers Drug Delivery Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Polymers Drug Delivery Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Polymers Drug Delivery Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Polymers Drug Delivery Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Polymers Drug Delivery Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Polymers Drug Delivery Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Polymers Drug Delivery Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Polymers Drug Delivery Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Polymers Drug Delivery Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Polymers Drug Delivery Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Polymers Drug Delivery Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Polymers Drug Delivery Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Polymers Drug Delivery Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eisai
  2. 8.1.1 Eisai Company Information
  3. 8.1.2 Eisai Business Overview
  4. 8.1.3 Eisai Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eisai Polymers Drug Delivery Product Portfolio
  6. 8.1.5 Eisai Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Polymers Drug Delivery Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Johnson & Johnson
  14. 8.3.1 Johnson & Johnson Company Information
  15. 8.3.2 Johnson & Johnson Business Overview
  16. 8.3.3 Johnson & Johnson Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Johnson & Johnson Polymers Drug Delivery Product Portfolio
  18. 8.3.5 Johnson & Johnson Recent Developments
  19. 8.4 Vectura Group Plc
  20. 8.4.1 Vectura Group Plc Company Information
  21. 8.4.2 Vectura Group Plc Business Overview
  22. 8.4.3 Vectura Group Plc Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Vectura Group Plc Polymers Drug Delivery Product Portfolio
  24. 8.4.5 Vectura Group Plc Recent Developments
  25. 8.5 Tolmar
  26. 8.5.1 Tolmar Company Information
  27. 8.5.2 Tolmar Business Overview
  28. 8.5.3 Tolmar Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Tolmar Polymers Drug Delivery Product Portfolio
  30. 8.5.5 Tolmar Recent Developments
  31. 8.6 SurModics
  32. 8.6.1 SurModics Company Information
  33. 8.6.2 SurModics Business Overview
  34. 8.6.3 SurModics Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  35. 8.6.4 SurModics Polymers Drug Delivery Product Portfolio
  36. 8.6.5 SurModics Recent Developments
  37. 8.7 Quark Pharmaceuticals Inc
  38. 8.7.1 Quark Pharmaceuticals Inc Company Information
  39. 8.7.2 Quark Pharmaceuticals Inc Business Overview
  40. 8.7.3 Quark Pharmaceuticals Inc Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Quark Pharmaceuticals Inc Polymers Drug Delivery Product Portfolio
  42. 8.7.5 Quark Pharmaceuticals Inc Recent Developments
  43. 8.8 Perrigo
  44. 8.8.1 Perrigo Company Information
  45. 8.8.2 Perrigo Business Overview
  46. 8.8.3 Perrigo Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Perrigo Polymers Drug Delivery Product Portfolio
  48. 8.8.5 Perrigo Recent Developments
  49. 8.9 Nektar Therapeutics
  50. 8.9.1 Nektar Therapeutics Company Information
  51. 8.9.2 Nektar Therapeutics Business Overview
  52. 8.9.3 Nektar Therapeutics Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Nektar Therapeutics Polymers Drug Delivery Product Portfolio
  54. 8.9.5 Nektar Therapeutics Recent Developments
  55. 8.10 Janssen Biotech
  56. 8.10.1 Janssen Biotech Company Information
  57. 8.10.2 Janssen Biotech Business Overview
  58. 8.10.3 Janssen Biotech Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Janssen Biotech Polymers Drug Delivery Product Portfolio
  60. 8.10.5 Janssen Biotech Recent Developments
  61. 8.11 Inovio Pharmaceuticals
  62. 8.11.1 Inovio Pharmaceuticals Company Information
  63. 8.11.2 Inovio Pharmaceuticals Business Overview
  64. 8.11.3 Inovio Pharmaceuticals Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Inovio Pharmaceuticals Polymers Drug Delivery Product Portfolio
  66. 8.11.5 Inovio Pharmaceuticals Recent Developments
  67. 8.12 Heron
  68. 8.12.1 Heron Company Information
  69. 8.12.2 Heron Business Overview
  70. 8.12.3 Heron Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Heron Polymers Drug Delivery Product Portfolio
  72. 8.12.5 Heron Recent Developments
  73. 8.13 Gilead Sciences
  74. 8.13.1 Gilead Sciences Company Information
  75. 8.13.2 Gilead Sciences Business Overview
  76. 8.13.3 Gilead Sciences Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Gilead Sciences Polymers Drug Delivery Product Portfolio
  78. 8.13.5 Gilead Sciences Recent Developments
  79. 8.14 Enzon Pharmaceuticals
  80. 8.14.1 Enzon Pharmaceuticals Company Information
  81. 8.14.2 Enzon Pharmaceuticals Business Overview
  82. 8.14.3 Enzon Pharmaceuticals Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Enzon Pharmaceuticals Polymers Drug Delivery Product Portfolio
  84. 8.14.5 Enzon Pharmaceuticals Recent Developments
  85. 8.15 EnColl Corporation
  86. 8.15.1 EnColl Corporation Company Information
  87. 8.15.2 EnColl Corporation Business Overview
  88. 8.15.3 EnColl Corporation Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  89. 8.15.4 EnColl Corporation Polymers Drug Delivery Product Portfolio
  90. 8.15.5 EnColl Corporation Recent Developments
  91. 8.16 Allergan
  92. 8.16.1 Allergan Company Information
  93. 8.16.2 Allergan Business Overview
  94. 8.16.3 Allergan Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Allergan Polymers Drug Delivery Product Portfolio
  96. 8.16.5 Allergan Recent Developments
  97. 8.17 Alkermes
  98. 8.17.1 Alkermes Company Information
  99. 8.17.2 Alkermes Business Overview
  100. 8.17.3 Alkermes Polymers Drug Delivery Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Alkermes Polymers Drug Delivery Product Portfolio
  102. 8.17.5 Alkermes Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst